title: Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage.
abstract: OBJECTIVE
  Elevated intracranial pressure is one of the proposed mechanisms leading to poor outcomes in patients with intraventricular hemorrhage. We sought to characterize the occurrence and significance of intracranial hypertension in severe intraventricular hemorrhage requiring extraventricular drainage.
  
  
  METHODS
  Prospective analysis from two randomized, multicenter, clinical trials.
  
  
  METHODS
  Intensive care units of 23 academic hospitals.
  
  
  METHODS
  One hundred patients with obstructive intraventricular hemorrhage and intracerebral hemorrhage volume <30 mL requiring emergency extraventricular drainage from two randomized multicenter studies comparing intraventricular recombinant tissue plasminogen activator (n=78) to placebo (n=22).
  
  
  METHODS
  Intracranial pressure was recorded every 4 hrs in all patients and before and after a 1-hr extraventricular drainage closure period after injection. Intracranial pressure readings were analyzed at predefined thresholds and compared between treatment groups, before and after injection of study agent, and before and after opening of third and fourth ventricles on computed tomography. Impact on 30-day outcomes was assessed.
  
  
  RESULTS
  Initial intracranial pressure ranged from -2 to 60 mm Hg (median; interquartile range, 11;10). Of 2576 intracranial pressure readings, 91.5% (2359) were ≤20 mm Hg, 1.6% were >30, 0.5% were >40, and 0.2% were >50 mm Hg. In a multivariate analysis, threshold events>20 mm Hg and >30 mm Hg were more frequent in placebo vs. recombinant tissue plasminogen activator-treated groups (p=.03 and p=.08, respectively). Intracranial pressure elevation>20 mm Hg occurred during a required 1-hr extraventricular drainage closure interval in 207 of 868 (23.8%) injections of study agent, although early reopening of the extraventricular drainage only occurred in 7.9%. After radiographic opening of the lower ventricular system, intracranial pressure events>20 mm Hg remained significantly associated with initial intraventricular hemorrhage volume (p=.002) and extraventricular drainage placement ipsilateral to the largest intraventricular hemorrhage volume (p=.001), but not with thrombolytic treatment (p=.05) or intracerebral hemorrhage volume (p=.14). Ventriculoperitoneal shunts were required in 13.6% of placebo and 6.4% of recombinant tissue plasminogen activator-treated patients (p=.37). Percentage of intracranial pressure readings per patient>30 mm Hg and initial intracerebral hemorrhage and intraventricular hemorrhage volumes were independent predictors of 30-day mortality after adjustment for other outcome predictors (p=.003, p=.03, and p<.001, respectively). Independent predictors of poor modified Rankin Scale score at 30 days were percent of intracranial pressure events>30 mm Hg per patient (p=.01; but not >20 mm Hg), both intracerebral hemorrhage and intraventricular hemorrhage volume, and pulse pressure.
  
  
  CONCLUSIONS
  Intracranial pressure is not frequently elevated during monitoring and drainage with an extraventricular drainage in patients with severe intraventricular hemorrhage, although intracranial pressure >30 mm Hg predicts higher short-term mortality. Thrombolytic therapy may reduce the frequency of high intracranial pressure events. Intracranial pressure elevation appears to be significantly correlated with extraventricular drainage placement in the ventricle with greatest clot volume.
authors.affiliation: Department of Neurology, Division of Neurocritical Care, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. weziai@jhmi.edu
authors.forename: Wendy C
authors.initials: WC
authors.lastname: Ziai
authors.forename: Eric
authors.initials: E
authors.lastname: Melnychuk
authors.forename: Carol B
authors.initials: CB
authors.lastname: Thompson
authors.forename: Issam
authors.initials: I
authors.lastname: Awad
authors.forename: Karen
authors.initials: K
authors.lastname: Lane
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Hanley
mesh_terms: D000328:Adult; D000368:Aged; D002543:Cerebral Hemorrhage / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D004322:Drainage; D005260:Female; D006801:Humans; D019586:Intracranial Hypertension / Q000209:etiology* / Q000601:surgery / Q000628:therapy; D007427:Intracranial Pressure / Q000502:physiology; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D011994:Recombinant Proteins / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D017287:Ventriculoperitoneal Shunt
chemical_list: D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator